Resources

A multicenter, randomized, double-blind, placebo-controlled, parallel-group study found that combining linagliptin treatment with a sulfonylurea (SU) in diabetic patients was well tolerated and produced statistically significant and clinically relevant A1c reductions….

Barbers in Texas showed that they can participate in healthcare by helping to screen and reduce blood pressure. A cadre of barbers, true to their healthcare-provider heritage, participated in a hypertension-screening outreach experiment that helped many of their customers with hypertension to get their blood pressures under control….

A novel insulin that releases over several days showed similar efficacy to standard insulin but without an advantage for hypoglycemia in its first full phase III study….

However, as diabetes has surged actual number of cases rose, review of U.S. data found….

By Iriny Nashed, PharmD Candidate Just when we thought we had it all figured out when it comes to diabetes management, we find there are not only new drugs on the horizon but new classes of medications that might just change the entire outlook on diabetes treatments.

  OVERVIEW: Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Presently, the Company is focused on diseases affecting the back of the eye, or retina. The company recently submitted a New Drug Application to the …

ILUVIEN® — an intravitreal insert for the treatment of diabetic macular edema (DME) Iluvien, which has the potential to be the first FDA-approved prescription product for DME, is a sustained release intravitreal insert.   Iluvien is inserted in the back of the patient’s eye to a position that takes advantage of …

Older, more diverse population and longer lifespans contribute to increase….

The use of long-term low-dose aspirin reduced both the incidence and the mortality associated with colorectal cancer, a 20-year follow-up of randomized trials showed.…

There is an association between Type 2 diabetes and colorectal cancer (CRC) among men, but not women, according to a published study.…